1.A Comparative Study of Three Imaging Modalities for Size Selection of a Watchman Left Atrial Appendage Closure Device
Zhong-bao RUAN ; Fei WANG ; Ge-cai CHEN ; Li ZHU
Yonsei Medical Journal 2022;63(4):325-332
Purpose:
To compare the results of computed tomography angiography (CTA), transesophageal echocardiography (TEE), and digital subtraction angiography (DSA) measurements and analyze their accuracy, correlation, and consistency in patients who have successfully undergone left atrial appendage closure (LAAC).
Materials and Methods:
A total of 157 non-valvular atrial fibrillation (AF) patients who underwent LAAC with Watchman devices were included in the study. The maximum diameter and depth of LAA were recorded using CTA, TEE, and DSA. Correlations and agreements were compared.
Results:
The LAAC procedure was performed successfully in all patients using the Watchman device. There was no significant difference between DSA and TEE measurements of the diameter of the LAA ostium. LAA ostium diameter obtained by CTA, however, was greater than that from DSA and TEE. Correlations were good between LAA ostium diameter measured by TEE, CTA, and DSA and Watchman device size. DSA measurements and actual device size showed the widest limits of agreement, followed by TEE; CTA measurements showed the narrowest limits of agreement. For LAA depth measurements, mean CTA measurements were higher than those of TEE and DSA. There was no significant difference in depth measurements among the three imaging modalities.
Conclusion
CTA, TEE, and DSA measurements exhibited good correlations with Watchman device size. The ostium diameter and depth of the LAA measured by CTA were greater than those measured by TEE and DSA. The relevance and concordance of CTA measurements were the strongest.
2.Effect of roots of Ficus hirta on cocaine-induced hepatotoxicity and active components.
Qing-yuan CAI ; Hu-biao CHEN ; Shao-qing CAI ; Zhong-zhen ZHAO ; Ming RUAN ; Feng-lan JIA ; Tung OU ; Bao-xu ZHANG
China Journal of Chinese Materia Medica 2007;32(12):1190-1193
OBJECTIVETo investigate the protective effect of the roots of F. hirta against the cocaine-induced hepatotoxicity and it's active components.
METHODCocaine hydrochloride was subcutaneously injected to make male ICR mice liver wounded. Male ICR mice were randomly ig administered with the F. hirta decoction. The dose groups are 100, 200, 300 g x kg(-1) herb materials per body weight. Cocaine hydrochloride was subcutaneously injected into the mice after the administration. The serum ALT, AST activity and the activity of CAT in liver homogenate were assayed, and liver change of pathomorphism was evaluated to prove the effect of the F. hirta decoction on cocaine-induced hepatotoxicity. And the activity of psoralean which was separated from the F. hirta decoction by bioassay-guided fractionation, was proofed in the same method.
RESULTWe find that the F. hirta decoction shows a distinct effect on reducing serum transferase. The serum transferase and the content CAT in liver homogenate were dose-related reduced, and the histopathological examination found a significantly change of the liver tissues. And the psoralean, qua the mainly component, shows the same effect.
CONCLUSIONF. hirta has the protective effect against the cocaine-induced hepatotoxicity. Psoralean is the basis.
Alanine Transaminase ; blood ; Animals ; Aspartate Aminotransferases ; blood ; Catalase ; metabolism ; Chemical and Drug Induced Liver Injury ; Cocaine ; Drugs, Chinese Herbal ; isolation & purification ; pharmacology ; Ficus ; chemistry ; Ficusin ; isolation & purification ; pharmacology ; Liver ; drug effects ; enzymology ; pathology ; Liver Diseases ; blood ; prevention & control ; Male ; Mice ; Mice, Inbred ICR ; Plant Roots ; chemistry ; Plants, Medicinal ; chemistry ; Random Allocation
3.Step Fisher discriminant analysis on severe clinical features of hand foot and mouth disease between enterovirus (EV)71 and other EV
Feng RUAN ; Ai-Jun TAN ; Xue-Bao ZHANG ; Xue-Qin CHEN ; Song-Jian XIAO ; Zhong-Wen YE ; Song WANG
Chinese Journal of Epidemiology 2011;32(7):716-719
Objective To compare the clinical features of severe hand foot and mouth disease between enterovirus(EV)71 and other EV to find specific diagnosis index of EV71 severe hand foot and mouth disease.Methods Case definition were adopted from national guideline of hand foot and mouth disease diagnose(Version 2010).Clinical data of severe hand foot and mouth disease came from case history and contents of questionnaire would include the ones between the time of onset and diagnoses being made.EV and EV71,Cox A16 nucleic acid tested were by RT-PCR in stopl samples.Clinical features of severe hand foot and mouth disease between EV71 and other EV were compare.Results There appeared statistical differences between neurologic symptoms such as tremor,myoclonic jerk,listlessness,convulsion and white blood cell counts in CSF(P<0.05).Results from the step Fisher discriminant analysis showed only tremor and white blood cell had an increase in CSF,with statistically significant differences.The discriminant equation of EV71 was Y=3.059X1+3.83X5-2.742 and the equation of other EV was Y=1.634X1+1.623X5-1.693.The specificity of EV71 was 91% and the specificity of other EV Was 40%.Conclusion The increase of clinical features of tremor and white blood cell in CSF could be used as diagnosis index of severe EV71.
4. Retraction notice to “Effect of phentolamine on myocardial extracellular matrix of cardiac remodeling in rats” (Asian Pacific Journal of Tropical Medicine (2014) 7(8) (645–649) (S1995764514601085) (10.1016/S1995-7645(14)60108-5))
Yi-Gang YIN ; Ru-Zhu WANG ; Zhong-Bao RUAN ; Li ZHU
Asian Pacific Journal of Tropical Medicine 2017;10(7):722-722
This article has been retracted at the request of the journal Editorial Office. The authors have plagiarized part of a paper that had already appeared in Chinese Journal of Arteriosclerosis 2014, 4, 362–366. Article id: 1007-3949 (2014) 22-04-0362-05. One of the conditions of submission of a paper for publication is that authors declare explicitly that their work is original and has not appeared in a publication elsewhere. Re-use of any data should be appropriately cited. As such this article represents an abuse of the scientific publishing system. The scientific community takes a very strong view on this matter and apologies are offered to readers of the journal that this was not detected during the submission process.
5.First-line Xeloda (Capecitabine) treatment for advanced and recurrent colorectal cancer.
Zhong-zhen GUAN ; Dong-geng LIU ; Bao-ming YU ; Wei-qin WU ; De SHI ; Yu ZHAO ; Yu-quan WEI ; Li-qun ZOU ; Xiao-ding WU ; Wen ZHUANG ; Feng-yi FENG ; Pin ZHANG ; Shi-ying YU ; Hui-hua XIONG ; Qiang FU ; Shu ZHENG ; Jian-jin HUANG ; Gang WU ; Chuan-yong YANG ; Sheng-rong SUN ; Qing-lan RUAN
Chinese Journal of Oncology 2004;26(2):119-121
OBJECTIVETo evaluate the efficacy and safety of capecitabine as first-line therapy in patients with advanced and recurrent colorectal cancer.
METHODSFrom December 2000 to November 2001, sixty patients with advanced and recurrent colorectal cancer received first-line capecitabine treatment given at a dose of 1250 mg/m(2) twice daily, on days 1 - 14 every 21 days. At least 2 cycles were administered.
RESULTSThe overall response rate was 23.3% with 14 PR, 24 SD (40.0%) and 15 PD. The median survival time was 14.7 months. The survival rate was 63.9% at 12-months and 33.4% at 24-months. Grade III-IV adverse effects were diarrhea in 4 patients (6.6%), anemia in 2 (3.3%) and hand-foot syndrome (HFS) in 1 (1.7%); Grade I-II adverse effects were hyperpigmentation in 20 (33.3%), HFS in 18 (30.0%) and diarrhea in 10 (16.7%).
CONCLUSIONCapecitabine is an efficacious and better-tolerated alternative treatment for the patients with advanced and recurrent colorectal cancer.
Adult ; Aged ; Antimetabolites, Antineoplastic ; therapeutic use ; Capecitabine ; Colorectal Neoplasms ; drug therapy ; mortality ; Deoxycytidine ; adverse effects ; analogs & derivatives ; therapeutic use ; Female ; Fluorouracil ; analogs & derivatives ; Humans ; Male ; Middle Aged ; Survival Rate